New Delhi: Bharat Biotech has commenced direct supply of its COVID-19 vaccine ‘Covaxin’ to 14 states, including Delhi and Maharashtra, with effect from 1 May, according to the company’s Joint Managing Director Suchitra Ella.
The Hyderabad-based firm has started supplying its COVID-19 treatment vaccine to the states based on the allocations received by the central government.
Glad to announce 🇮🇳Bharat Biotech confirms direct supplies of COVAXIN to the following state govt’s since 1/5/21, based on the allocations received by GoI. Requests have been received from other states, & will be processed for distribution based on availability of stocks 24×7🙏🏼 pic.twitter.com/OHrgXnw5Mj
— suchitra ella (@SuchitraElla) May 8, 2021
The company is supplying vaccines to Andhra Pradesh, Assam, Chhattisgarh, Gujarat, Jammu & Kashmir, Jharkhand, Madhya Pradesh, Odisha, Tamil Nadu, Telangana, Uttar Pradesh, and West Bengal.
On 29 April, Bharat Biotech announced a cut in the price of ‘Covaxin’ for states to Rs 400 per dose from the earlier Rs 600 per dose.
This followed widespread criticism of its pricing policy as it sold Covaxin to the central government at Rs 150 per dose.
India has announced the expansion of its COVID-19 vaccination drive by allowing its large 18-plus population to get inoculated from 1 May.